Uncategorized
Retinopathy of Prematurity Pipeline Review 2016 Featuring Biomar Microbial Technologies & F. Hoffmann-La Roche Ltd. – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Retinopathy Of Prematurity - Pipeline Review, H2 2016" report to their offering. Retinopathy Of Prematurity pipeline therapeutics constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. Our latest report Retinopathy Of Prematurity - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Retinopathy Of Prematurity, complete w
